MindMaze Therapeutics Holding S.A.
RLFTY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$36.28M
Close$
$0.14
18.9% downside
Current Fair Value
18.9% downsideOvervalued by 18.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $36.28 Million |
|---|---|
| Enterprise Value | $29.69 Million |
| Earnings per Share | $-0.79 |
| Beta | 3.02 |
| Outstanding Shares | 153,780,529 |
Return
| Return on Equity | -70.02% |
|---|---|
| Return on Assets | -57.04% |
| Return on Invested Capital | -72.94% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 7.16 |
| Enterprise Value to EBIT | -0.89 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About MindMaze Therapeutics Holding S.A.
31 employees
CEO: Zach W. Henderson
MindMaze Therapeutics Holding SA develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology. MindMaze Therapeutics Holding SA was formerl...